Back | Next |
home / stock / mrna / mrna message board
Subject | By | Source | When |
---|---|---|---|
They just wanted to drop the price so | Civil War General | investorshub | 04/18/2023 11:08:13 AM |
The profound observed reduction in the risk of | axelvento | investorshub | 04/18/2023 4:12:01 AM |
the results of the trial- which shows reduced | axelvento | investorshub | 04/18/2023 3:26:52 AM |
Yes as always! | axelvento | investorshub | 04/18/2023 2:56:52 AM |
Thats nonsense | Civil War General | investorshub | 04/17/2023 9:21:03 PM |
The news on the cancer vaccine was fine, | DewDiligence | investorshub | 04/17/2023 8:11:59 PM |
And on Monday with this excellent news the | Civil War General | investorshub | 04/17/2023 7:36:46 PM |
That is old fried rice from Catherine Wu | NY1972 | investorshub | 04/17/2023 11:57:04 AM |
the story continues-with phase 3 launch before year-end! | axelvento | investorshub | 04/17/2023 3:26:08 AM |
additional subgroup analysis data will be presented during | axelvento | investorshub | 04/17/2023 3:20:35 AM |
More on mRNA-1427 from Evaluate Vantage: | DewDiligence | investorshub | 04/16/2023 10:29:14 PM |
Thanks. Your previous two posts had the information | DewDiligence | investorshub | 04/16/2023 9:47:23 PM |
Slides https://s29.q4cdn.com/435878511/files/doc presentations/2023/Apr/16/MMA-7 | jondoeuk | investorshub | 04/16/2023 9:27:30 PM |
https://finance.yahoo.com/news/moderna-merck-announce-mrna-4157-150000175.html | jondoeuk | investorshub | 04/16/2023 3:22:25 PM |
Dr. Weber will give an oral presentation today https://www.abstractsonline.com/pp8/#!/10828/presenta | jondoeuk | investorshub | 04/16/2023 2:03:38 AM |
imo...$MRNA is a POS trainwreck~ | IHuser | investorshub | 04/15/2023 11:10:13 PM |
When will the full dataset be presented? | DewDiligence | investorshub | 04/15/2023 5:57:47 PM |
https://twitter.com/TedAshburn/status/1646649256206299136 | jondoeuk | investorshub | 04/13/2023 11:04:30 PM |
US Court Favors Moderna In COVID-19 Vaccine Patent | axelvento | investorshub | 04/13/2023 1:22:10 PM |
Moderna said it expects to see between $8 | axelvento | investorshub | 04/12/2023 11:13:32 AM |
News, Short Squeeze, Breakout and More Instantly...
CAMBRIDGE, MA / ACCESSWIRE / July 10, 2024 / Moderna, Inc. (NASDAQ:MRNA), today announced that it will host a live conference call and webcast at 8:00 a.m. ET on Thursday, August 1, 2024 to report its second quarter 2024 financial results, and provide a corporate update. A live webcast of the c...
CAMBRIDGE, MA AND OSAKA, JAPAN / ACCESSWIRE / July 8, 2024 / Moderna, Inc. (Nasdaq:MRNA) and Mitsubishi Tanabe Pharma Corporation today announced that the companies have entered into a joint agreement regarding the co-promotion of Moderna's mRNA respiratory vaccine portfolio in Japan, including ...
CAMBRIDGE, MA / ACCESSWIRE / July 2, 2024 / Moderna, Inc. (NASDAQ:MRNA) today announced a project award of $176 million through the Rapid Response Partnership Vehicle (RRPV) to accelerate the development of mRNA-based pandemic influenza vaccines. The RRPV is a Consortium funded by the Biomedical...